Emmaus and Mitsubishi Tanabe Refuse To Take EU Approval Blows Quietly

Two companies explain why they believe the European Medicines Agency was wrong to say that they do not have sufficient study data to prove that their products should be approved for sale in the EU.

DoctorsDesk
The EMA says it needs more study data for Xyndari and Radicava • Source: Shutterstock

More from Europe

More from Geography